To learn more about our work in New York, please visit www.researchamerica.org/gh_newyork.
Thank you for watching the video of our April 9th, 2012 Forum: Global Health Research and Development in New York: Fueling Innovation and Saving Lives.
Please enjoy the conversation with Rep. Nita Lowey (D-NY), influential global health commentator Laurie Garrett and renowned New York researchers and industry leaders in global health centering around the progress that research and development (R&D) in New York has yielded in the past decade — globally and here at home.
Hear the latest developments in global health R&D in New York, including how the president’s 2013 budget and congressional action may affect the future of global health locally and worldwide. Speakers share their insights on how innovative partnerships for global health R&D are transforming how we do business, making New York a leader in global health throughout the world and contributing to New York’s economy and to the health of Americans.
To hear more from moderator Laurie Garrett, watch the interview below.
Thank you for a valuable discussion. I realize the panel has just concluded, however, an issue to consider —
On using the funding & resources we do have more efficiently.
How can we maintain and increase the efficiency, or the return on our investments, in R&D? In particular by increasing our efforts in developing Responsible Conduct in Research, following basic scientific practices.
I ask this from the perspective of one who observed scientific misconduct 25 years ago, and the subsequent development of the RCR field (i.e. the Office of Research Integrity). This concern is primarily for NIH and other Federally–Funded research protocols.
[...] Rep. Nita Lowey (D-NY) made introductory remarks, in which she highlighted some of the impressive milestones that investments in global health by the U.S. and other global partners have achieved over the past few decades – including eliminating polio in all but three countries in the world, increasing life expectancy in many countries from 40 to 65 years, doubling child survival rates, and extending the lives of millions of people living with HIV/AIDS who previously would have faced certain death. [...]